Juvenile Idiopathic Arthritis clinical trials at UCSF
1 in progress, 0 open to eligible people
Showing trials for
Adalimumab in JIA-associated Uveitis Stopping Trial
Sorry, in progress, not accepting new patients
The proposed study is a stratified, block-randomized, double-masked, controlled trial to determine the feasibility of discontinuing adalimumab treatment in patients with quiescent uveitis associated with juvenile idiopathic arthritis (JIA) or chronic anterior uveitis (CAU).
San Francisco, California and other locations
Our lead scientists for Juvenile Idiopathic Arthritis research studies include Nisha Acharya.